Impact of Epstein-Barr virus in the clinical evolution of patients with classical Hodgkin's Lymphoma in Brazil

Hematological Oncology

Volumn 28, Issue 3, 2010, Pages 137-141

  Souza, Eni M ^a   Baiocchi, Otávio C G ^a   Zanichelli, Maria A ^b   Alves, Antonio C ^a   Assis, Marianne G ^a   Eiras, Daniel P ^a   Dobo, Cristine ^a   Oliveira, José S R ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Brigadeiro Hospital   (Brazil)

Author keywords

Epstein Barr virus; Hodgki s lymphoma; Prognostic

Indexed keywords

BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADULT; AGE; AGED; ARTICLE; BRAZIL; CANCER CHEMOTHERAPY; CANCER STAGING; EPSTEIN BARR VIRUS; EVENT FREE SURVIVAL; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REED STERNBERG CELL; SERODIAGNOSIS; SEX; ADOLESCENT; DISEASE FREE SURVIVAL; EPSTEIN BARR VIRUS INFECTION; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BRAZIL; DISEASE-FREE SURVIVAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 77957320227     PISSN: 02780232     EISSN: 10991069     Source Type: Journal    
DOI: 10.1002/hon.933     Document Type: Article

References (24)

1. Levine PH, Ablashi DV, Berard CW, Carbone PP, Waggoner DE, Malan L. Elevated antibody titers to Epstein Barr virus in Hodgkin's disease. Cancer 1971; 27: 416-421.
2. Gutensohn N, Cole P. Epidemiology of Hodgkin's disease. Semin Oncol 1980; 7: 92-102.
3. Mueller N, Evans A, Harris NL, et al. Hodgkin's disease and Epstein Barr virus. Altered antibody pattern before diagnosis. N Engl J Med 1989; 32: 689-695. (Pubitemid 19072487)
4. Glickman JN, Howe JG, Steitz JA. Structural analysis of EBER1 and EBER2 ribonucleoprotein particles present in Epstein Barr virus infected cells. J Virol 1988; 62: 902-911.
5. Murray PG, Young LS, Rowe M, Crocker J. Immunohistochemical demonstration of Epstein Barr virus encoded latent membrane protein in paraffin sections of Hodgkin's disease. J Pathol 1992; 166: 1-5.
6. Vassallo J, Metze K, Traina F, de Souza CA, Lorand-Metze I. Expression of Epstein-Barr virus in classical Hodgkin's lymphomas in Brazilian adult patients. Haematologica 2001; 86: 1227-1228. (Pubitemid 33063873)
7. Axdorph U, Porwit-MacDonald A, Sjöberg J, et al. Epstein-Barr virus expression in Hodgkin's disease in relation to patient characteristics, serum factors and blood lymphocyte function. Br J Cancer 1999; 81: 1182-1187.
8. Enblad G, Sandvej K, Sundström C, Pallesen G, Glimelius B. Epstein-Barr virus distribution in Hodgkin's disease in an unselected Swedish population. Acta Oncol 1999; 38: 425-429. (Pubitemid 29305716)
9. Murray PG, Billingham LJ, Hassan HT, et al. Effect of Epstein- Barr virus infection on response to chemotherapy and survival in Hodgkin's disease. Blood 1999; 94: 442-447.
10. Engel M, Essop MF, Close P, Hartley P, Pallesen G, Sinclair- Smith C. Improved prognosis of Epstein-Barr virus associated childhood Hodgkin's lymphoma: study of 47 South African cases. J Clin Pathol 2000; 53: 182-186.
11. Naresh KN, Johnson J, Srinivas V, et al. Epstein-Barr virus association in classical Hodgkin's disease provides survival advantage to patients and correlates with higher expression of proliferation markers in Reed-Sternberg cells. Ann Oncol 2000; 11: 91-96. (Pubitemid 30084586)
12. Glavina-Durdov M, Jakic-Razumovic J, Capkun V, Murray P. Assessment of prognostic impact of Epstein-Barr virus encoded latent membrane protein-1 expression in Hodgkin's disease. Br J Cancer 2001; 84: 1227-1234. (Pubitemid 32511341)
13. Clarke CA, Glaser SL, Dorfman RF, et al. Epstein-Barr virus and survival after Hodgkin disease in a population-based series of women. Cancer 2001; 91: 1579-1587. (Pubitemid 32319272)
14. Stark GL, Wood KM, Jack F, Angus B, Proctor SJ, Taylor PR. Hodgkin's disease in the elderly: a population-based study. Br J Haematol 2002; 119: 432-440. (Pubitemid 35365495)
15. Flavell KJ, Biddulph JP, Powell JE, et al. South Asian ethnicity and material deprivation increase the risk of Epstein-Barr virus infection in Hodgkin's disease. Br J Cancer 2001; 85: 350-356.
16. Herling M, Rassidakis GZ, Medeiros LJ, et al. Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome. Clin Cancer Res 2003; 9: 2114-2120. (Pubitemid 36687633)
17. Krugmann J, Tzankov A, Gschwendtner A, et al. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study. Mod Pathol 2003; 16: 566-573. (Pubitemid 36718438)
18. Jarrett RF, Stark GL, White J, et al. Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population- based study. Blood 2005; 106: 2444-2451. (Pubitemid 41510819)
19. Keegan TH, Glaser SL, Clarke CA, et al. Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study. J Clin Oncol 2005; 23: 7604-7613. (Pubitemid 46291824)
20. Kwon JM, Park YH, Kang JH, et al. The effect of Epstein-Barr virus status on clinical outcome in Hodgkin's lymphoma. Ann Hematol 2006; 85: 463-468. (Pubitemid 44283113)
21. Keresztes K, Miltenyi Z, Bessenyei B, et al. Association between the Epstein-Barr virus and Hodgkin's lymphoma in the North-Eastern part of Hungary: effects on therapy and survival. Acta Haematol 2006; 116: 101-107. (Pubitemid 44252765)
22. Dinand V, Dawar R, Arya LS, Unni R, Mohanty B, Singh R. Hodgkin's lymphoma in Indian children: prevalence and significance of Epstein-Barr virus detection in Hodgkin's and Reed-Sternberg cells. Eur J Cancer 2007; 43: 161-166. (Pubitemid 46054483)
23. Diepstra A, van Imhoff GW, Schaapveld M, et al. Latent Epstein- Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients. J Clin Oncol 2009; 27: 3815-3821.
24. Souza EM, Baiocchi OC, Zanichelli MA, Alves AC, Oliveira JS. Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study. Ann Hematol 2009; 88: 633-637.